{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:14Z","timestamp":1787027054601,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Metabolic-associated fatty liver disease (MAFLD) is becoming more common due to lifestyle changes. A long-term high-fat and high-glucose diet induces glycolipid metabolism disorders in the liver, which results in the development of MAFLD. To date, there is no specific clinically useful therapeutics for this disease. Natural products or synthetic compounds were screened and investigated to find effective agents for treating MAFLD. In this study, nootkatone (Nok), a natural sesquiterpene ketone isolated from\n                    <jats:italic>Alpiniae oxyphyllae<\/jats:italic>\n                    fructus, was explored for its potential to treat MAFLD, and underlying mechanisms were studied. Our results show that Nok dramatically ameliorated the disordered lipid and glucose metabolism in MAFLD mice, decreased fat accumulation in hepatic tissue, and improved liver injury. Inflammation, metabolic disorder, and oxidative stress were ameliorated in liver tissue based on RNA-seq transcriptome comparison between a Nok-treated group and an MAFLD model group. Furthermore, Nok significantly activated AMPK activity and inhibited MAPK activity\n                    <jats:italic>,<\/jats:italic>\n                    especially the p38 and JNK signaling pathways,\n                    <jats:italic>in vivo<\/jats:italic>\n                    based on western blot analysis. The pharmaceutical effects and potential signaling pathways impacted by Nok were also investigated in L02 cells. Nok significantly promoted the consumption of glucose and decreased the deposition of triglycerides\n                    <jats:italic>in vitro<\/jats:italic>\n                    . The p-AMPK\u03b1 level was notably upregulated by Nok, indicating dramatic AMPK activation. In addition, Nok decreased the levels of p-ERK1\/2, p-p38, and p-JNK. Nok also inhibited the activation of MAPK signaling and, thus, alleviated MAFLD development. Our results suggest that Nok may be useful in treating MAFLD. Nok may ameliorate MAFLD by regulating glycolipid metabolism disorders by activating AMPK and inhibiting MAPK activity. Collectively, this study suggests that Nok is an effective compound for the treatment of MAFLD.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2022.909280","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T02:44:24Z","timestamp":1656989064000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Nootkatone, a Sesquiterpene Ketone From Alpiniae oxyphyllae Fructus, Ameliorates Metabolic-Associated Fatty Liver by Regulating AMPK and MAPK Signaling"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhang","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Zibao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Ruiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Mimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Xiaowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhixuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Weiying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Xiaopo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/cdd.2008.148","article-title":"Tumour Cell Survival Signalling by the ERK1\/2 Pathway","volume":"16","author":"Balmanno","year":"2009","journal-title":"Cell Death Differ."},{"key":"B2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.tem.2018.08.003","article-title":"Role of Innate Immune Signaling in Non-alcoholic Fatty Liver Disease","volume":"29","author":"Cai","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.3390\/nu13113921","article-title":"Protective Effects of Nootkatone on Renal Inflammation, Apoptosis, and Fibrosis in a Unilateral Ureteral Obstructive Mouse Model","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/liv.14828","article-title":"Prevalence of NAFLD, MAFLD and Associated Advanced Fibrosis in the Contemporary United States Population","volume":"41","author":"Ciardullo","year":"2021","journal-title":"Liver Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/medicines5030106","article-title":"Effects of Shugan-Jianpi Recipe on the Expression of the P38 MAPK\/NF-\u03baB Signaling Pathway in the Hepatocytes of NAFLD Rats","volume":"5","author":"Deng","year":"2018","journal-title":"Med. (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"153074","DOI":"10.1016\/j.phymed.2019.153074","article-title":"Baicalin Ameliorates Hepatic Insulin Resistance and Gluconeogenic Activity through Inhibition of P38 MAPK\/PGC-1\u03b1 Pathway","volume":"64","author":"Fang","year":"2019","journal-title":"Phytomedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejphar.2015.11.043","article-title":"Betaine Prevented Fructose-Induced NAFLD by Regulating LXR\u03b1\/PPAR\u03b1 Pathway and Alleviating ER Stress in Rats","volume":"770","author":"Ge","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/hep.30820","article-title":"Sestrin 3 Protects against Diet-Induced Nonalcoholic Steatohepatitis in Mice through Suppression of Transforming Growth Factor \u03b2 Signal Transduction","volume":"71","author":"Huang","year":"2020","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/hep.31390","article-title":"Protective and Detrimental Roles of P38\u03b1 Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.mce.2013.05.021","article-title":"Hepatic ERK Activity Plays a Role in Energy Metabolism","volume":"375","author":"Jiao","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.freeradbiomed.2010.09.001","article-title":"Inhibition of Liver X Receptor-\u03b1-dependent Hepatic Steatosis by Isoliquiritigenin, a Licorice Antioxidant Flavonoid, as Mediated by JNK1 Inhibition","volume":"49","author":"Kim","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.dsx.2020.09.026","article-title":"Pathophysiological Mechanisms Underlying MAFLD","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.tem.2017.10.007","article-title":"Mitogen-activated Protein Kinase Regulation in Hepatic Metabolism","volume":"28","author":"Lawan","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/MCB.00503-14","article-title":"Hepatic Mitogen-Activated Protein Kinase Phosphatase 1 Selectively Regulates Glucose Metabolism and Energy Homeostasis","volume":"35","author":"Lawan","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"289264","DOI":"10.1155\/2014\/289264","article-title":"Antioxidant and Anti-inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus","volume":"2014","author":"Li","year":"2014","journal-title":"Evidence-Based Complementary Altern. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jpba.2016.02.035","article-title":"Metabonomic Study of the Fruits of Alpinia Oxyphylla as an Effective Treatment for Chronic Renal Injury in Rats","volume":"124","author":"Li","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B19","doi-asserted-by":"publisher","first-page":"111167","DOI":"10.1016\/j.biopha.2020.111167","article-title":"Alpiniae Oxyphyllae Fructus and Alzheimer's Disease: An Update and Current Perspective on This Traditional Chinese Medicine","volume":"135","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD Diagnostic Criteria in Real World","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int."},{"key":"B21","doi-asserted-by":"crossref","first-page":"153000","DOI":"10.1016\/j.phymed.2019.153000","article-title":"Nootkatone, an AMPK Activator Derived from Grapefruit, Inhibits KRAS Downstream Pathway and Sensitizes Non-small-cell Lung Cancer A549 Cells to Adriamycin","volume":"63","author":"Moon","year":"2019","journal-title":"Phytomedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E266","DOI":"10.1152\/ajpendo.00774.2009","article-title":"Nootkatone, a Characteristic Constituent of Grapefruit, Stimulates Energy Metabolism and Prevents Diet-Induced Obesity by Activating AMPK","volume":"299","author":"Murase","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1038\/s41598-020-59485-3","article-title":"Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-alcoholic Fatty Liver Disease","volume":"10","author":"Musolino","year":"2020","journal-title":"Sci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of Nonalcoholic Fatty Liver Disease: Role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","article-title":"AMPK: Restoring Metabolic Homeostasis over Space and Time","volume":"81","author":"Trefts","year":"2021","journal-title":"Mol. Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.intimp.2018.06.042","article-title":"Nootkatone, a Neuroprotective Agent from Alpiniae Oxyphyllae Fructus, Improves Cognitive Impairment in Lipopolysaccharide-Induced Mouse Model of Alzheimer's Disease","volume":"62","author":"Wang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3892\/mmr.2016.5966","article-title":"Inhibition of JNK Suppresses Autophagy and Attenuates Insulin Resistance in a Rat Model of Nonalcoholic Fatty Liver Disease","volume":"15","author":"Yan","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12038-018-9746-5","article-title":"Chlorogenic Acid Alleviates Autophagy and Insulin Resistance by Suppressing JNK Pathway in a Rat Model of Nonalcoholic Fatty Liver Disease","volume":"43","author":"Yan","year":"2018","journal-title":"J. Biosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/tox.23073","article-title":"Nootkatone Improves Anxiety- and Depression-like Behavior by Targeting Hyperammonemia-Induced Oxidative Stress in D-Galactosamine Model of Liver Injury","volume":"36","author":"Yan","year":"2021","journal-title":"Environ. Toxicol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/4084566","article-title":"Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways","volume":"2021","author":"Yong","year":"2021","journal-title":"J. Immunol. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"108505","DOI":"10.1016\/j.jnutbio.2020.108505","article-title":"Combination of Metformin and Genistein Alleviates Non-alcoholic Fatty Liver Disease in High-Fat Diet-Fed Mice","volume":"87","author":"Zamani-Garmsiri","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"B33","first-page":"1624","article-title":"Signal Transductions and Nonalcoholic Fatty Liver: a Mini-Review","volume":"7","author":"Zeng","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/liv.12120","article-title":"GLP-1 Analogue Prevents NAFLD in ApoE KO Mice with Diet and Acrp30 Knockdown by Inhibiting C-JNK","volume":"33","author":"Zhang","year":"2013","journal-title":"Liver Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jcmgh.2020.04.005","article-title":"SIRT6 Protects against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells","volume":"10","author":"Zhong","year":"2020","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine Attenuates Nonalcoholic Hepatic Steatosis through the AMPK-SREBP-1c-SCD1 Pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic. Biol. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.909280\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T02:44:30Z","timestamp":1656989070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.909280\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":36,"alternative-id":["10.3389\/fphar.2022.909280"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.909280","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"article-number":"909280"}}